Life Competitors
| LABS Stock | 38.60 0.10 0.26% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Life Science competition on your existing holdings.
Life |
Life Science Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Life Science and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Life and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Life Science REIT does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Life Stock performing well and Life Science Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Life Science's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DLN | 0.94 | (0.35) | 0.00 | (0.70) | 0.00 | 1.25 | 7.03 | |||
| HMSO | 1.11 | (0.17) | 0.00 | 2.16 | 0.00 | 2.01 | 8.58 | |||
| WKP | 1.27 | (0.40) | 0.00 | (1.24) | 0.00 | 2.01 | 8.98 | |||
| SUPR | 0.73 | (0.13) | 0.00 | (0.81) | 0.00 | 1.71 | 5.97 | |||
| 0K2K | 1.02 | 0.09 | 0.07 | 0.18 | 0.94 | 2.56 | 7.75 | |||
| XLM | 1.67 | 0.00 | 0.00 | 0.03 | 3.49 | 2.63 | 50.54 | |||
| 0HW4 | 1.60 | 0.14 | 0.04 | (0.32) | 2.24 | 3.38 | 19.79 | |||
| 0HOY | 0.75 | 0.09 | 0.07 | 0.52 | 0.78 | 1.42 | 6.85 | |||
| RIO | 1.09 | (0.05) | 0.00 | (0.14) | 0.00 | 3.13 | 9.45 | |||
| PREM | 6.05 | 0.45 | 0.05 | 0.38 | 7.96 | 15.38 | 70.70 |
Cross Equities Net Income Analysis
Compare Life Science REIT and related stocks such as Derwent London PLC, Hammerson PLC, and Workspace Group PLC Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DLN | 463 K | 228.3 M | 226.9 M | 456.6 M | 737.7 M | 766.2 M | 58.7 M | 314 M | 222.3 M | 283.4 M | (77.6 M) | 252.3 M | (280.5 M) | (476.4 M) | (452.6 M) |
| HMSO | 34.7 M | 335.7 M | 138.4 M | 337.4 M | 699.1 M | 726.8 M | 317.3 M | 388.4 M | (268.1 M) | (575.7 M) | (1.7 B) | (409.3 M) | (164.2 M) | (51.4 M) | (48.8 M) |
| WKP | 577 K | 49 M | 76.4 M | 241.4 M | 350.9 M | 388.9 M | 88.7 M | 171.4 M | 137.3 M | 72.1 M | (235.7 M) | 123.9 M | (37.8 M) | (192.5 M) | (182.9 M) |
| SUPR | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 10.6 M | 32.8 M | 82 M | 110.3 M | (144.9 M) | (21.2 M) | (20.1 M) |
| 0K2K | 441.5 M | 441.5 M | 565.3 M | 565.3 M | 513.5 M | 359.5 M | 2 B | 1.6 B | 1.1 B | 241.7 M | (949 M) | 1 B | (175.3 M) | 948.9 M | 508.5 M |
| XLM | 3.6 M | 7.6 M | 12.2 M | 8.8 M | 9.8 M | 18.7 M | 23.9 M | 30.3 M | 19.8 M | (60.9 M) | 792 K | 5.6 M | 2.4 M | (47 M) | (44.7 M) |
| 0HW4 | (304 M) | (304 M) | (304 M) | (169 M) | (183 M) | (271 M) | 3.5 B | 9.9 B | 1.2 B | 1.7 B | 3.2 B | 4.7 B | 5.1 B | 4.6 B | 3 B |
| 0HOY | (4.1 B) | (4.1 B) | (4.1 B) | (121 M) | (119 M) | (239 M) | 347 M | 104 M | 1.7 B | 4.7 B | (82 M) | 1 B | 698 M | 1.6 B | 1.7 B |
| RIO | 248.7 M | 5.8 B | (3 B) | 3.7 B | 6.5 B | (866 M) | 4.6 B | 8.8 B | 13.6 B | 8 B | 9.8 B | 21.1 B | 12.4 B | 10.1 B | 10.6 B |
| PREM | (998.8 K) | (998.8 K) | (2.1 M) | (3.8 M) | 14 K | (6 M) | (3.4 M) | (23.7 M) | (11.6 M) | (565 K) | (923 K) | 7.3 M | (6.5 M) | (20.4 M) | (19.4 M) |
Life Science REIT and related stocks such as Derwent London PLC, Hammerson PLC, and Workspace Group PLC Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Life Science REIT financial statement analysis. It represents the amount of money remaining after all of Life Science REIT operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Life Science Competitive Analysis
The better you understand Life Science competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Life Science's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Life Science's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Life Science Competition Performance Charts
Five steps to successful analysis of Life Science Competition
Life Science's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Life Science REIT in relation to its competition. Life Science's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Life Science in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Life Science's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Life Science REIT, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Life Science position
In addition to having Life Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run RUB Crypto Assets Thematic Idea Now
RUB Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Russian Ruble. The RUB Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize RUB Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.